Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,675,787
+$559,509 QoQ
Shares Held
600,619
+33.2% QoQ
Ownership
0.993%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. VNDA ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,675,787 | 600,619 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,116,278 | 450,981 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,784,775 | 429,113 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,268,313 | 454,572 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,167,064 | 459,124 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,246,224 | 489,374 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,430,645 | 507,442 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,350,434 | 501,159 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,751,046 | 486,911 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,033,380 | 494,740 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,146,227 | 508,585 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,424,974 | 561,337 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,924,344 | 595,500 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,048,759 | 596,283 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,330,708 | 586,023 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,874,547 | 594,590 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,508,835 | 597,141 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,751,039 | 596,909 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,430,416 | 792,251 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $13,702,949 | 799,472 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 2,788,528 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $17,641,489 | 820,153 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 ALXN | — | 2,710,339 | Shares | Other | 2021-05-12 | |
| 2021-03-31 | $9,397,561 | 625,670 | Shares | Other | 2021-05-12 | |
| 2020-12-31 ALXN | — | 2,756,159 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $8,544,047 | 650,232 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 ALXN | — | 2,810,217 | Shares | Other | 2020-11-16 | |
| 2020-09-30 | $6,606,732 | 683,927 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 ALXN | — | 2,820,770 | Shares | Other | 2020-08-14 | |
| 2020-06-30 | $8,140,141 | 711,551 | Shares | Other | 2020-08-14 | |
| 2020-03-31 ALXN | — | 2,771,424 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $7,459,985 | 720,076 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||